The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Racial/ethnic (RE) differences in the occurrence of HER2 and hormone receptor (HR)-defined breast cancer (BC) in California (CA).
Scarlett Lin Gomez
Research Funding - Genentech
Lisa Wang
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Laura Chu
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Marjorie C. Green
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Chunyan Song
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Lisa M Moy
Research Funding - Genentech
Juan Yang
Research Funding - Genentech
Li Tao
Research Funding - Genentech
Christina A Clarke
Research Funding - Genentech
Expert Testimony - Littlepage Booth, representing plaintiff in Prempro litigation